The Asia Pacific Pharmaceutical Gelatin Market should witness market growth of 6.2% CAGR during the forecast period (2022-2028).
Regenerative medicine is the amalgamation of molecular biology and tissue engineering. Its purpose is to repair and regenerate diseased or injured tissue using the patient’s own cells. In this area, gelatin helps in cell growth and imitates the extracellular matrix and hence acts as a useful biomaterial. It facilitates improved cell viability. It is necessary to minimize pyrogens and endotoxins in regenerative medicine, which is made possible with the use of gelatin after ensuring that it is highly purified. This ensures high performance and patient safety.
Thermoreversible ability at a temperature between 25°C and 32°C enables gelling grade gelatin to reverse melting and setting. Gelling-grade gelatin is a versatile material that has varied applications. One of the primary reasons for its versatility is the dependency of exact transition temperature on the type and concentration of gelatin that is used. Gelling grade gelatin’s bloom value measures the firmness of the gelled products. Due to the incapability to form a gel, a hydrolyzed gelatin possesses a bloom value of 0.
Further, gelatin, as a natural protein, furnish high biocompatibility and is well-bearable by the human body. Melting of gelatin at body temperature makes it applicable for the pharmaceutical industry, which is highly beneficial since it provides the best solutions to the problems where metabolization is required by pharma-medical.
The Chinese government is increasing its investment in R&D and healthcare. China’s pharmaceutical industry is growing due to its rising health awareness, total per capita expenditure on healthcare, and aging population. Whereas, in Japan, biopharmaceutical is responsible for around 15% of drug sales, and sales for biopharmaceutical are around 30% of all pharmaceutical sales globally. The rising pharmaceutical industry across the regional nations will also support the pharmaceutical gelatin market in the Asia Pacific region.
The China market dominated the Asia Pacific Pharmaceutical Gelatin Market by Country in 2021; thereby, achieving a market value of $139.9 million by 2028. The Japan market is registering a CAGR of 5.5% during (2022-2028). Additionally, The India market would showcase a CAGR of 6.9% during (2022-2028).
Based on Type, the market is segmented into Type B and Type A. Based on Source, the market is segmented into Porcine, Bovine Skin, Bovine Bone, Marine, and Poultry. Based on Function, the market is segmented into Stabilizing Agent, Thickening Agent, and Gelling Agent & Others. Based on Application, the market is segmented into Hard Capsules, Softgel Capsules, Tablets, Absorbable Hemostats, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Australia, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Darling Ingredients, Inc., Nitta Gelatin, Inc., Tessenderlo Group nv, Gelita AG, SAS Gelatines Weishardt, Lonza Group Ltd. (Capsugel), Norland Products, Inc., Roxlor Group and Catalent, Inc.
Regenerative medicine is the amalgamation of molecular biology and tissue engineering. Its purpose is to repair and regenerate diseased or injured tissue using the patient’s own cells. In this area, gelatin helps in cell growth and imitates the extracellular matrix and hence acts as a useful biomaterial. It facilitates improved cell viability. It is necessary to minimize pyrogens and endotoxins in regenerative medicine, which is made possible with the use of gelatin after ensuring that it is highly purified. This ensures high performance and patient safety.
Thermoreversible ability at a temperature between 25°C and 32°C enables gelling grade gelatin to reverse melting and setting. Gelling-grade gelatin is a versatile material that has varied applications. One of the primary reasons for its versatility is the dependency of exact transition temperature on the type and concentration of gelatin that is used. Gelling grade gelatin’s bloom value measures the firmness of the gelled products. Due to the incapability to form a gel, a hydrolyzed gelatin possesses a bloom value of 0.
Further, gelatin, as a natural protein, furnish high biocompatibility and is well-bearable by the human body. Melting of gelatin at body temperature makes it applicable for the pharmaceutical industry, which is highly beneficial since it provides the best solutions to the problems where metabolization is required by pharma-medical.
The Chinese government is increasing its investment in R&D and healthcare. China’s pharmaceutical industry is growing due to its rising health awareness, total per capita expenditure on healthcare, and aging population. Whereas, in Japan, biopharmaceutical is responsible for around 15% of drug sales, and sales for biopharmaceutical are around 30% of all pharmaceutical sales globally. The rising pharmaceutical industry across the regional nations will also support the pharmaceutical gelatin market in the Asia Pacific region.
The China market dominated the Asia Pacific Pharmaceutical Gelatin Market by Country in 2021; thereby, achieving a market value of $139.9 million by 2028. The Japan market is registering a CAGR of 5.5% during (2022-2028). Additionally, The India market would showcase a CAGR of 6.9% during (2022-2028).
Based on Type, the market is segmented into Type B and Type A. Based on Source, the market is segmented into Porcine, Bovine Skin, Bovine Bone, Marine, and Poultry. Based on Function, the market is segmented into Stabilizing Agent, Thickening Agent, and Gelling Agent & Others. Based on Application, the market is segmented into Hard Capsules, Softgel Capsules, Tablets, Absorbable Hemostats, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Australia, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Darling Ingredients, Inc., Nitta Gelatin, Inc., Tessenderlo Group nv, Gelita AG, SAS Gelatines Weishardt, Lonza Group Ltd. (Capsugel), Norland Products, Inc., Roxlor Group and Catalent, Inc.
Scope of the Study
By Type
- Type B
- Type A
By Source
- Porcine
- Bovine Skin
- Bovine Bone
- Marine
- Poultry
By Function
- Stabilizing Agent
- Thickening Agent
- Gelling Agent & Others
By Application
- Hard Capsules
- Softgel Capsules
- Tablets
- Absorbable Hemostats
- Others
By Country
- China
- Japan
- India
- South Korea
- Australia
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Darling Ingredients, Inc.
- Nitta Gelatin, Inc.
- Tessenderlo Group nv
- Gelita AG
- SAS Gelatines Weishardt
- Lonza Group Ltd. (Capsugel)
- Norland Products, Inc.
- Roxlor Group
- Catalent, Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Pharmaceutical Gelatin Market, by Type
1.4.2 Asia Pacific Pharmaceutical Gelatin Market, by Source
1.4.3 Asia Pacific Pharmaceutical Gelatin Market, by Function
1.4.4 Asia Pacific Pharmaceutical Gelatin Market, by Application
1.4.5 Asia Pacific Pharmaceutical Gelatin Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Pharmaceutical Gelatin Market
Chapter 4. Asia Pacific Pharmaceutical Gelatin Market by Type
4.1 Asia Pacific Type B Market by Country
4.2 Asia Pacific Type A Market by Country
Chapter 5. Asia Pacific Pharmaceutical Gelatin Market by Source
5.1 Asia Pacific Porcine Market by Country
5.2 Asia Pacific Bovine Skin Market by Country
5.3 Asia Pacific Bovine Bone Market by Country
5.4 Asia Pacific Marine Market by Country
5.5 Asia Pacific Poultry Market by Country
Chapter 6. Asia Pacific Pharmaceutical Gelatin Market by Function
6.1 Asia Pacific Stabilizing Agent Market by Country
6.2 Asia Pacific Thickening Agent Market by Country
6.3 Asia Pacific Gelling Agent & Others Market by Country
Chapter 7. Asia Pacific Pharmaceutical Gelatin Market by Application
7.1 Asia Pacific Hard Capsules Market by Country
7.2 Asia Pacific Softgel Capsules Market by Country
7.3 Asia Pacific Tablets Market by Country
7.4 Asia Pacific Absorbable Hemostats Market by Country
7.5 Asia Pacific Others Market by Country
Chapter 8. Asia Pacific Pharmaceutical Gelatin Market by Country
8.1 China Pharmaceutical Gelatin Market
8.1.1 China Pharmaceutical Gelatin Market by Type
8.1.2 China Pharmaceutical Gelatin Market by Source
8.1.3 China Pharmaceutical Gelatin Market by Function
8.1.4 China Pharmaceutical Gelatin Market by Application
8.2 Japan Pharmaceutical Gelatin Market
8.2.1 Japan Pharmaceutical Gelatin Market by Type
8.2.2 Japan Pharmaceutical Gelatin Market by Source
8.2.3 Japan Pharmaceutical Gelatin Market by Function
8.2.4 Japan Pharmaceutical Gelatin Market by Application
8.3 India Pharmaceutical Gelatin Market
8.3.1 India Pharmaceutical Gelatin Market by Type
8.3.2 India Pharmaceutical Gelatin Market by Source
8.3.3 India Pharmaceutical Gelatin Market by Function
8.3.4 India Pharmaceutical Gelatin Market by Application
8.4 Australia Pharmaceutical Gelatin Market
8.4.1 Australia Pharmaceutical Gelatin Market by Type
8.4.2 Australia Pharmaceutical Gelatin Market by Source
8.4.3 Australia Pharmaceutical Gelatin Market by Function
8.4.4 Australia Pharmaceutical Gelatin Market by Application
8.5 South Korea Pharmaceutical Gelatin Market
8.5.1 South Korea Pharmaceutical Gelatin Market by Type
8.5.2 South Korea Pharmaceutical Gelatin Market by Source
8.5.3 South Korea Pharmaceutical Gelatin Market by Function
8.5.4 South Korea Pharmaceutical Gelatin Market by Application
8.6 Malaysia Pharmaceutical Gelatin Market
8.6.1 Malaysia Pharmaceutical Gelatin Market by Type
8.6.2 Malaysia Pharmaceutical Gelatin Market by Source
8.6.3 Malaysia Pharmaceutical Gelatin Market by Function
8.6.4 Malaysia Pharmaceutical Gelatin Market by Application
8.7 Rest of Asia Pacific Pharmaceutical Gelatin Market
8.7.1 Rest of Asia Pacific Pharmaceutical Gelatin Market by Type
8.7.2 Rest of Asia Pacific Pharmaceutical Gelatin Market by Source
8.7.3 Rest of Asia Pacific Pharmaceutical Gelatin Market by Function
8.7.4 Rest of Asia Pacific Pharmaceutical Gelatin Market by Application
Chapter 9. Company Profiles
9.1 Nitta Gelatin, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Sales Category and Regional Analysis
9.1.4 Recent strategies and developments:
9.1.4.1 Product Launches and Product Expansions:
9.2 Tessenderlo Group nv
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expenses
9.2.5 Recent strategies and developments:
9.2.5.1 Product Launches and Product Expansions:
9.3 Lonza Group Ltd. (Capsugel)
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expenses
9.3.5 Recent strategies and developments:
9.3.5.1 Product Launches and Product Expansions:’
9.4 Catalent, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Regional & Segmental Analysis
9.4.4 Research & Development Expenses
9.4.5 Recent strategies and developments:
9.4.5.1 Product Launches and Product Expansions:
9.5 Darling Ingredients, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Recent strategies and developments:
9.5.4.1 Partnerships, Collaborations, and Agreements:
9.5.4.2 Product Launches and Product Expansions:
9.6 GELITA AG
9.6.1 Company Overview
9.6.2 Recent strategies and developments:
9.6.2.1 Partnerships, Collaborations, and Agreements:
9.6.2.2 Acquisition and Mergers:
9.7 Roxlor Group
9.7.1 Company Overview
9.8 Norland Products, Inc.
9.8.1 Company Overview
9.9 SAS Gelatines Weishardt
9.9.1 Company Overview
Companies Mentioned
- Darling Ingredients, Inc.
- Nitta Gelatin, Inc.
- Tessenderlo Group nv
- Gelita AG
- SAS Gelatines Weishardt
- Lonza Group Ltd. (Capsugel)
- Norland Products, Inc.
- Roxlor Group
- Catalent, Inc.
Methodology
LOADING...
